N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent-Reference-Cited by-同舟云学术

N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent

Published:2004-03-01 Issue:7 Volume:47 Page:1719-1728
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Misra Raj N.¹,Xiao Hai-yun¹,Kim Kyoung S.¹,Lu Songfeng¹,Han Wen-Ching¹,Barbosa Stephanie A.¹,Hunt John T.¹,Rawlins David B.¹,Shan Weifang¹,Ahmed Syed Z.¹,Qian Ligang¹,Chen Bang-Chi¹,Zhao Rulin¹,Bednarz Mark S.¹,Kellar Kristen A.¹,Mulheron Janet G.¹,Batorsky Roberta¹,Roongta Urvashi¹,Kamath Amrita¹,Marathe Punit¹,Ranadive Sunanda A.¹,Sack John S.¹,Tokarski John S.¹,Pavletich Nikola P.¹,Lee Francis Y. F.¹,Webster Kevin R.¹,Kimball S. David¹

Affiliation:

1. Bristol-Myers Squibb Pharmaceutical Research Institute, PO Box 4000, Princeton, New Jersey 08543-4000

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0305568

Reference32 articles.

1. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age

2. Cancer Cell Cycles

3. A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types

4. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK9 inhibitors for the treatment of solid tumors;Biochemical Pharmacology;2024-11

2. Insights into the structural and functional activities of forgotten Kinases: PCTAIREs CDKs;Molecular Cancer;2024-06-29

3. Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications;Journal of Medicinal Chemistry;2024-04-02

4. Recent Progress in CDK4/6 Inhibitors and PROTACs;Molecules;2023-12-13

5. Design, Synthesis, Anticancer Screening and Molecular Modelling Studies of Novel Thiazoles;ChemistrySelect;2023-11-08